SUDA Prospers Via Drug Delivery Partnerships: A Quick Review of Deals Transacted for ZolpiMistTM

Oro-mucosal drug delivery giant, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the pharmaceutical development of drug delivery technology. To increase bioavailability, the company...

Insight into Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceutical’s FY19 Annual Report

Australian-headquartered global pharmaceutical leader, SUDA Pharmaceuticals Limited (ASX: SUD) is engaged in the reformulation of existing drugs and provision of medication via the oral...
SUDA

SUDA Pharmaceuticals Progressing Well in 2019 with Significant Regulatory and Patent Approvals

Australia’s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) develops low-risk, easy-to-use oral sprays using its OroMist® technology to reformulate existing medications....

SUDA’s OroMist® Technology Revamping Pharmaceutical Industry

Australian headquartered pharmaceutical giant, SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery leader, engaged in the reformulation of existing medications into oral...
Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

Drugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of...

SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery

Australia’s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) produces reliable oral sprays by using its proprietary OroMist® technology to redevelop the...

SUDA Makes Speedy Progress with its Robust Product Pipeline

SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative...
SUDA’s Science

SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide...

SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, focusses on developing low-risk oral sprays using its proprietary OroMist® oro-mucosal...
SUDA

SUDA welcomes Australian Government’s Initiatives to Foster Medical Marijuana Industry

To increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceuticals Ltd (ASX: SUD) is reformulating medications into an oral spray. The delivery of medications...
SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results

SUDA Pharmaceuticals: Pharmacy And Pharmacology Journal Publishes Impressive ZolpiMistTM Clinical Study Results

SUDA Pharmaceuticals Ltd (ASX: SUD) is an oro-mucosal drug delivery company that is reformulating medication into an oral spray to improve the bioavailability of...

SUDA’s June Quarterly Report Out On ASX; A Look At Its Business And Technology

On 31 July 2019, SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery firm, has released its June quarterly updates on the ASX. SUDA...

SUDA’s MD and CEO, Mr Stephen Carter Back on Board

An oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) uses its OroMist® technology for the development of low-risk oral sprays....

SUDA Receives Patent For The Only Effective Medicine For Platelet Reduction, Anagrelide; Stock Soars...

With the rise in cases of the deadly disease cancer creating havoc across the globe, it is the need of the hour for the...

A look at SUDA Pharmaceuticals’ Product Portfolio

Headquartered in Western Australia, SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug-delivery pharmaceutical company that develops low-risk, innovative pharmaceuticals to improve the health and...
SUD

SUDA Publishes Product Development Update; 11 Deals Transacted

SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug delivery company. It is headquartered in Perth, Australia. The company focuses on oro-mucosal administration. Currently, the...
SUD

SUDA Pharmaceuticals develops oral spray product for cancer prevention

A drug-delivery pharmaceutical company, SUDA Pharmaceuticals has recently identified the use of platelets as surrogate biomarkers in cancer risk that can potentially reduce the...
Suda Pharmaceuticals

Suda Pharmaceuticals Is All Set To Commercialize SUD-001H

Suda Pharmaceuticals Limited (ASX:SUD) announced regarding its entry into an exclusive product development, licence and supply agreement with the fully owned subsidiary of Strides Pharma...

Latest News

Editorial